REPORTED PARTICIPANT
NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIIA
24 Jul 2026 – 4 Aug 2026 · NSE
Reported activity over time
Purchases and sales from published disclosures only
Most disclosed companies
OFFICIAL SHAREHOLDING PATTERNS
Disclosed holdings under this name
0 matched filing rows · latest available filing per company
Only individually named holdings disclosed in available shareholding-pattern filings are shown. Reporting thresholds, missing filings and name differences leave other holdings unobserved. A name match is not verification of a legal identity; absence is not a zero holding. Estimated values use reported shares times an unadjusted official close no later than the reporting date, within seven calendar days; holdings without an eligible close have no value estimate. Scroll horizontally if needed.
2 possible matches with different name formatting
These names match only after punctuation, spacing or ampersand changes. They are separate candidates and are not included in the matched holdings above.
| Company / reported name | As of | Shares | Company stake | Estimated value | Category | Evidence |
|---|---|---|---|---|---|---|
| SUDEEP PHARMA LIMITEDNuvama Crossover Opportunities Fund - Series Iii A | 30 Sept 2026 | 12,18,850 | 1.08% | ₹146.9689 CrRaw close ₹1205.80 · 30 Sept 2026 NSE | named shareholder | Official filing ↗NSE · formatting-only candidate |
| Manipal Payment and Identity Solutions LtdNuvama Crossover Opportunities Fund - Series Iii A | 16 Sept 2026 | 43,31,746 | 1.87% | UnavailableNo eligible EOD close | public | Public table ↗ · Promoter table ↗BSE · formatting-only candidateLinked by BSE company code |
Complete disclosure history
Prices per share · ₹ · Values count reported sides · Scroll horizontally if needed
Scroll horizontally to see all columns →
| Date / exchange | Company | Reported participant | Side | Quantity | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-04NSEBlock | Sudeep Pharma LimitedSUDEEPPHRM | NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIIA | Sell | 5,62,360 | ₹850 | ₹47.80 Cr | NSE ↗ |
| 2026-07-24NSEBulk | Sudeep Pharma LimitedSUDEEPPHRM | NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIIA | Sell | 9,40,000 | ₹800 | ₹75.20 Cr | NSE ↗ |
| 2026-07-24NSEBlock | Sudeep Pharma LimitedSUDEEPPHRM | NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIIA | Sell | 9,40,000 | ₹800 | ₹75.20 Cr | NSE ↗ |
Names as reported
NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIIA
BLOCK.DEAL ARCHIVE
Company profileParticipant profileDaily disclosuresLoading page…
Retrieving the published disclosures.
Loading history…
BLOCK.DEAL ARCHIVE
Deal explorerSource receipt
Retrieving the requested published data.
Loading selection…